Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cell-Based Reparative Therapies for Multiple Sclerosis.
The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system.
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.
Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.
Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
Alemtuzumab in the treatment of multiple sclerosis.
Specialized housing and transportation needs of adults with multiple sclerosis.
Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation.
Immune cell dynamics in the CNS: Learning from the zebrafish.
Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases.
Type I IFN receptor controls activated TYK2 in the nucleus: Implications for EAE therapy.
Resilience Predicts Functional Outcomes in People Aging with Disability: A Longitudinal Investigation.
Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.
[Assessment of the effectiveness and safety of Sativex ® in compassionate use].
Tumefactive multiple sclerosis in taiwan.
Leukotrienes induce the migration of Th17 cells.
The conceptualization and development of a patient-reported neurogenic bladder symptom score.
C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.
Multifocal VEP assessment of optic neuritis evolution.
Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis.
Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease.
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect.
A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders.
HINT1 peptide/Hsp70 complex induces NK cell-dependent immunoregulation in a model of autoimmune demyelination.
Pages
« first
‹ previous
…
518
519
520
521
522
523
524
525
526
…
next ›
last »